Cite

HARVARD Citation

    Han, J. et al. (2021). Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 9 (10), pp. 1141-1153. [Online]. 
  
Back to record